About this Event
"New Directions in T-cell (CAR-T/BiTE) Therapy Related Cardiotoxicity"
Speaker:
Dae Hyun Lee, M.D.
Assistant Professor of Medicine
Cardiovascular Division
Perleman School of Medicine
University of Pennsylvania
About Dae Hyun Lee:
Dr. Lee holds a bachelor's degree in statistics and information from Korean National Open University in Seoul, South Korea. He rececived his medical degree from Inha University School of Medicine in Incheon, South Korea.
His clinical interests include cardiovascular risk factor in patients with cancer. He has expertise in cardiotoxicity associated with cancer therapies, including cellular immunotherapy.
Dr. Lee’s research examines how cancer treatments influence cardiovascular aging, immune function, and long‑term cardiac outcomes. His work focuses on clonal hematopoiesis of indeterminate potential (CHIP) as a driver of cardiovascular risk and a potential therapeutic target, while also contributing to studies of cardiotoxicity after CAR‑T therapy, immune checkpoint inhibitor–related cardiovascular effects, and heart‑transplant rejection biomarkers. His goal is to advance precision cardiovascular care for patients with cancer.